Context: Excessive body iron stores are a risk factor for decreased insulin sensitivity (S I ) and diabetes. We hypothesized that transcriptional dysregulation of genes involved in iron metabolism in adipocytes causes insulin resistance.
I
ron plays a central role in many essential biochemical processes in human physiology. The cell's need for iron in the face of its potential danger as an oxidant has given rise to a complex system to tightly regulate its levels, tissue distribution, and bioavailability. Thus, disorders in iron metabolism have serious consequences. Pathologic iron overload due to hereditary hemochromatosis or frequent blood transfusions is associated with diabetes risk and other multiorgan damage and dysfunction (1) . Within the broad range of normal levels in the general population, higher iron levels are also associated with a threefold to fivefold increased risk of diabetes (2) (3) (4) . In rodent diabetes models, iron plays a direct role in causing insulin deficiency and insulin resistance, as well as determining fuel choice and disrupting the circadian rhythm of hepatic glucose production, all of which are cardinal aspects of type 2 diabetes (T2D) (5) (6) (7) (8) (9) .
Several organs involved both in iron homeostasis and metabolic regulation are likely to play major roles in ironmediated T2D pathogenesis (10) . Among these, initiation of pathways in adipose tissue has been shown to be sufficient to result in systemic insulin resistance and diabetes (11) (12) (13) (14) . Several abnormalities associated with adipose dysfunction in T2D, including adipokine production, inflammation/fibrosis, and adipocyte differentiation, are affected by tissue iron levels (7, 15, 16) .
We therefore hypothesized that determining the transcriptional regulatory mechanisms of iron metabolism pathway genes in human adipose tissue might elucidate causal mechanisms of insulin resistance and mechanisms of T2D onset and progression. We report herein the relationship between insulin sensitivity (S I ) and transcript levels of selected genes in subcutaneous adipose tissue from individuals of African American and European ancestry. Expression quantitative trait analysis identified single nucleotide polymorphisms (SNPs) associated with adipose tissue transcript levels of a subset of these S I -associated iron metabolism pathway genes. Among the S I -associated transcripts, the strongest cisregulatory genetic variant [cis-expression regulatory SNP (cis-eSNP)] was identified for transferrin (TF), a key ironbinding protein and known previously to be made primarily in the liver to act as the serum iron transporter. TF-bound iron enters cells after endocytosis of the TFreceptor (TFRC). Our in vitro studies in human adipocytes demonstrate that genetic downregulation of TF expression causes insulin resistance by modulating expression of genes involved in multiple cellular mechanisms linked to metabolism and insulin action, including glucose transport, mitochondrial function, Wnt-signaling, and genes with novel roles in obesity.
Materials and Methods

Human subjects
The study primarily used available glucometabolic phenotype, gene expression, and genotype data from 256 unrelated and nondiabetic individuals from the African American Genetics of Metabolism and Expression (AAGMEx) cohort. Participants were healthy, self-reported African Americans residing in North Carolina and aged 18 to 60 years with a body mass index (BMI) between 18 and 42 kg/m 2 . A standard 75-g oral glucose tolerance test was used to exclude individuals with diabetes, and fasting blood samples were drawn for DNA isolation and biochemical analyses. Subcutaneous adipose tissue and skeletal muscle biopsy specimens were collected by Bergstrom needle under overnight fasting conditions and frequently sampled IV glucose tolerance test was performed to evaluate S I and secretion. Clinical, anthropometric, and physiological characteristics of the AAGMEx cohort have been described (17) . To validate the glucometabolic phenotypetranscript association, we used subcutaneous adipose tissue genome-wide transcript expression data from an independent cohort of 99 nondiabetic European Americans from Arkansas (AREA) cohort whose S I was characterized by our laboratory using a similar frequently sampled IV glucose tolerance test protocol (18) . Additional replication of our findings was tested in a published gene expression study in adipose tissue samples from the European Ancestry individuals in Metabolic Syndrome in Men cohort (METSIM, Finland; n = 770) (19) . Oral glucose tolerance test -derived insulin sensitivity data (Matsuda Index) is available for METSIM participants.
All participants provided written informed consent under protocols approved by the institutional review boards at Wake Forest School of Medicine (for the AAGMEx cohort) and the University of Arkansas for Medical Sciences (for the AREA cohort).
Laboratory and statistical methods are described briefly in the following paragraphs. Please see Supplemental Methods for additional details.
Laboratory measures and physiological phenotypes
Details of clinical laboratory measurers have been described (17, 18) . TF (catalog no. OKIA00085; Aviva System Bio, San Diego, CA) and ferritin (catalog no. EHFTL; Invitrogen, Carlsbad, CA) were measured in plasma samples using ELISA kits.
Gene expression analysis and genotyping methods
Details of gene expression analysis, genotyping, and data quality control methods for all human cohorts are published elsewhere (17, 18) . Genome-wide expression data in AAGMEx were generated using HumanHT-12, version 4, Expression BeadChip (Illumina, San Diego, CA) whole-genome gene expression arrays for quantitative analyses of transcript expression in adipose and muscle tissue samples. In the METSIM cohort, Affymetrix U219 array (Thermo Fisher Scientific, Waltham, MA) was used to generate adipose tissue expression data. Infinium HumanOmni5Exome-4, version 1.1, DNA Analysis BeadChips (Illumina) were used to genotype DNA samples from the AAGMEx cohort and based on manufacturer instructions. Genotyping of METSIM samples was performed with the Illumina Human OmniExpress BeadChip array and the Illumina Human CoreExome array.
Bioinformatics and statistical methods
Our genome-wide analysis reported association of S I with expression levels of 2212 transcripts [false discovery rate (FDR) , 1%] in adipose tissue (17) . The adipose transcript with the second strongest association (inversely) with S I is the heavy chain of the iron storage protein ferritin heavy polypeptide 1 (FTH1). However, based on DAVID, version 6.7 (https://david. ncifcrf.gov/), and IPA (Build version 321501M; Content version 21249400; QIAGEN Inc., qiagenbioinformatics.com/ products/ingenuity-pathway-analysis/), we did not identify enrichment of any iron metabolism pathways among these S Iassociated transcripts. Considering the incompleteness in annotation of pathway databases and differences in pathway knowledge bases used in enrichment analyses tools, we performed an ad hoc analysis using g:GOSt Gene group functional profiling analysis tool (in g:Profiler; https://biit.cs.ut.ee/gprofiler/). The g:Profiler analysis identified significant enrichment for iron transport (GO:0006826; P = 0.00261) and iron uptake and transport (REAC:917937; P = 0.0281) genes, which include 17 S I -associated transcripts. To perform focused analyses on the role of genes in iron metabolism pathways in regulating glucometabolic phenotypes in this study, we manually curated a list of 43 genes involved in tissue and systemic iron homeostasis, based on the literature. These genes were represented in the Human HT-12, version 4, Expression BeadChip as 62 transcript probes (Supplemental Table 1 ) and in Affymetrix U219 array data as 113 probes.
Studies in cultured adipocyte models
Expression of TF at different stages of differentiation was studied in human adipose stroma-derived stem cells (ADSCs). To identify the role of the TF in adipocytes, we used SimpsonGolabi-Behmel syndrome (SGBS) preadipocytes, a wellcharacterized human adipocyte cell model (20) . For stable RNA interference, the TF gene was silenced by infecting the SGBS preadipocytes with lentiviral particles to deliver a genespecific short hairpin RNA (shRNA) expression vector (catalog no. sc-37176-V; Santa Cruz Biotechnology, Santa Cruz, CA). For iron treatment, ferric ammonium citrate (Fe; 100 mM), or Fe plus desferrioxamine (100 mM), were added 24 hours before harvest.
Determination of Fe; western blot
The Supplemental Methods describes how Fe determination was accomplished by microwave plasma atomic emission spectrometry, and also outlines our western blot procedure.
2-Deoxyglucose uptake assay
Glucose uptake in human adipocyte SGBS cells with shRNA mediated knockdown of TF (TF shRNA) and control (control shRNA) was measured using the glucose uptake assay kit (catalog no. ab136955; Abcam, Cambridge, UK) following the manufacturer's instructions.
RNA sequencing analysis and bioinformatics
We performed genome-wide expression profiling of controland TF-shRNA SGBS cells in triplicate at day 14 of differentiation by RNA sequencing. The RNA-sequencing experiments were performed at Beijing Genome Institute (Beijing, China).
Results
Glucometabolic phenotypes were associated with expression of iron metabolism pathway genes in adipose tissue but not in muscle
In adipose tissue of African Americans from AAGMEx, 40 transcript probes representing iron metabolism pathway genes were significantly expressed in .50% of the participants. Among these expressed transcripts in adipose tissue, 24 were significantly inversely associated and six were significantly positively associated with S I (P , 0.001, a Bonferroni threshold for 40 transcripts tested; Supplemental Table 2A ). Expression of FTH1 in adipose tissue was most significantly inversely associated (b = 21.21; ). TFRC expression was also significantly inversely associated with S I (b= 20.55; P = 2.79 3 10
25
). Among the adipose transcripts, 31 and 30 were also associated (P , 0.001) with Matsuda index and BMI, respectively. In skeletal muscle of African Americans from AAGMEx, 36 transcript probes representing iron metabolism pathway genes were significantly expressed in .50% of the participants. In contrast to adipose tissue, only two transcripts (ATP6V1A and SLC40A1) in muscle showed significant association with S I (P , 0.001; Supplemental Table 3 ).
The association between the transcript level of iron metabolism pathway genes in subcutaneous adipose tissue and S I and BMI was replicated in European Americans from the AREA cohort. Spearman semipartial correlation analysis results from this published data set also showed the strongest positive correlation of S I with TF (Spearman r = 0.35; P = 0.0004) and inverse correlation with FTH1 (Spearman r = 20.446; P , 0.0001) among 40 wellexpressed probes for iron metabolism pathway genes (Supplemental Table 4A ; Supplemental Fig. 1 ). We observed strong concordance in effect direction and effect size (r 2 = 0.64). All S I -associated probes, except one, in AAGMEx showed the same effect direction in AREA (Supplemental Table 2B ). In addition, results from a cohort of European ancestry men of the METSIM study also supported an association between the transcript level of iron metabolism pathway genes in subcutaneous adipose and S I (Supplemental Table 4B Transcript levels of TF in adipose tissue were determined by genetic regulatory polymorphisms Genotype variation can lead to gene expression variation, but the converse is biologically impossible. Thus, SNPs that regulate gene expression, eSNPs, are "causal anchors" in determination of genetically regulated expression level of transcripts. In expression quantitative trait loci (eQTL) analysis, we integrated SNP genotypes with transcript expression of iron metabolism pathway genes from AAGMEx participants. We identified significant cis-eSNPs for 19 transcripts at a FDR ,1% in adipose tissue (Supplemental Table 5 ). Among these 19 cis-expression regulated genes (cis-eGenes), 16 were associated with S I or other glucometabolic phenotypes (Table 1 ). The strongest cis-eGenes include ferredoxin 1 (FDX1; P = 2.39 3 10
218
), and TF (P = 7.84 3 10
). FDX1 expression in adipose tissue was only marginally associated with S I and other glucometabolic traits (P = 0.047 to 0.0005); however, as described in the preceding section, TF expression level was strongly associated with S I , Matsuda index, and BMI (P = 7.84 3 10 26 to 1.39 3 10
211
; Fig.-1A and 1B). We identified 49 cis-SNPs (FDR ,1%) for TF in subcutaneous adipose tissue of AAGMEx participants (Supplemental Table 7 ). Among the genotyped SNPs, a SNP in the intron of TF showed the strongest association with its mRNA level (rs6796795_G; b = 1.161, P = 5.98 3 10
216
; Fig. 1C ). Within 235 bp of this cis-eSNP, an imputed SNP rs6785596_A showed slightly stronger association with TF mRNA level (b = 0.962, P = 7.84 3 10
218
; Fig. 1D ). Minor alleles of both of these SNPs were associated with higher expression of TF mRNA. SNPs in the putative promoter region (within 1 kb upstream of the transcription start site) of the TF gene were also associated with TF mRNA level. For example, the minor allele of SNP rs8177181_A was associated with lower expression of the TF transcript (b = 20.727, P = 2.21 3 10
26
). Statistical analysis indicated low linkage disequilibrium (r 2 = 0.31) between these two cis-regulatory regions, suggesting they may independently regulate the transcription of TF mRNA in adipose tissue. A stepwise regression analysis in the TF ciseQTL region with 95 cis-eSNPs, and adjusted for top ciseSNP rs6785596, identified a significant independent association of an imputed SNP rs200005012 with TF transcript level in the final model (rs200005012_T; stepwise b = -0.64, P = 2.01 3 10
25
). Independent replication of these cis-eSNPs of TF in adipose tissue was observed in publicly available eQTL data from GTEx_V6 (rs6785596_A; b = 0.92, P = 2.28 3 10
215
) and METSIM (rs6785596; P = 8.10 3 10
289
) projects, which primarily include individuals of European ancestry (Supplemental Tables 8A and 8B ).
In muscle tissue of AAGMEX participants, we identified significant cis-eQTLs for six iron metabolism pathway genes, including ATPase H+ transporting V0 subunit b (ATP6V0B; P = 3.65 3 10 256 ) and FDX1 (P = 3.85 3 10 225 ; Supplemental Table 6 ). Expression of TF was only detected at levels near background in muscle of most of the AAGMEx subjects. Multitissue eQTL analysis in the GTEx_V6 data set revealed significant ciseSNPs for TF in subcutaneous and visceral adipose tissue (rs6785596 being the top eSNP in both tissues), but found no cis-eSNP for TF in skeletal muscle or liver (Supplemental Table 8B ). Similarly, eQTL analysis in seven tissues from the STARNET (Stockholm-Tartu Atherosclerosis Reverse Networks Engineering Task) cohort detected strong cis-eQTL for TF in subcutaneous and visceral adipose tissue (rs1800277 being the top eSNP in both tissues), but not for liver or skeletal muscle (Supplemental Table 8C ). Thus, our studies in human cohorts suggest a putative role for genetic regulation of TF levels specifically in adipose tissue in modulating S I .
Relationship of plasma transferrin and ferritin level, genotype of transferrin eSNP and S I Genotype of the eSNPs for TF mRNA in adipose tissue was not significantly associated with plasma transferrin or ferritin levels in the AAGMEx cohort (Table 2) . Plasma ferritin is a marker for tissue iron load, and in this cohort, S I was significantly lower (age and sex adjusted P = 0.026) in individuals with higher plasma ferritin levels (.100 ng/dL) compared with individuals with lower plasma ferritin levels (,100 ng/dL), as has been reported in numerous other populations (2) (3) (4) 21) . Alleles of cis-eSNPs for the TF transcript were not significantly associated with S I in AAGMEx. However, stratifying individuals on the basis of low and high ferritin levels and genotype of an eSNP whose minor allele is associated with low TF mRNA expression in adipose tissue (rs8177181_A), we found that the relation of plasma ferritin levels and S I is different as a function of TF genotype. Major allele homozygotes for rs8177181 (T/T, high TF) show the expected relation, namely individuals with low serum ferritin levels have significantly greater S I than those with higher ferritin levels (age and sex adjusted P = 0.006). That relation is lost in the individuals with the rs8177181_A allele (T/A and A/A) that decreases adipocyte TF (Fig. 2) . Their S I values are lower even with lower ferritin, suggesting increased sensitivity to tissue iron levels.
In adipose tissue, TF is primarily expressed in adipocytes
To define the cells in adipose tissue responsible for the observed relationship between TF expression and S I , we fractionated fresh adipose tissue into adipocytes and adipose stromal vascular cells, as described (22) . Total RNA extracted from five or six African American individuals from AAGMEx was used to prepare separate pools of adipocyte fraction and stromal vascular fraction cDNA. Adiponectin (ADIPOQ) and CD68 are markers of adipocytes and vascular cells, respectively, and demonstrate purity of the fractionated cell populations. In a quantitative RT-PCR (qRT-PCR) assay (in technical triplicates), TF expression was almost undetectable in RNA from the stromal vascular fraction but was clearly expressed in the adipocyte fraction of adipose tissue (Supplemental Fig. 2A ).
TF expression was strongly induced in mature adipocytes
We analyzed the expression of TF transcripts at different stages of in vitro differentiation of human ADSCs (primary preadipocytes). TF expression was almost undetectable in undifferentiated cells, began to rise in cells after 7 days in differentiation media, and was strongly induced 14 days after differentiation (average log 2 fold change, 13.35 compared with undifferentiated cells; Supplemental Fig. 2B ).
Knocking down of TF mRNA levels in SGBS adipocyte affected intracellular iron and S I
The role of TF in human adipocytes was studied by downregulating its expression in SGBS cells, a cell type more amenable to genetic manipulation than ADSCs but that also has an expression profile after differentiation that closely mimics adipose tissue (23) . Adipocytes showed .10 4 -fold induction of TF expression with differentiation and, compared with control shRNA, SGBS cells infected with the TF-specific shRNA [TF knockdown (TF-KD)] showed 60% to 80% downregulation of TF mRNA at 7 and 14 days after differentiation (Fig. 3A) . Western blot analysis confirmed downregulation of TF protein ( Fig. 3B and 3C) . The only known function of TF is its involvement in blood iron transport and cellular iron uptake. We therefore hypothesized that it might play a paracrine or autocrine role in regulating iron uptake in adipose tissue. Iron content of TF-KD cells was decreased by 23% (P = 0.023) compared with in control cells (Fig. 4A) . Because insulin resistance was the defining characteristic of individuals with the low TF mRNA, we next determined if decreasing TF expression in cultured human adipocytes (i.e., SGBS cells) replicated this phenotype. Insulinstimulated glucose uptake was significantly (P , 0.01) decreased in differentiated TF-shRNA SGBS cells (TF-KD) compared with uptake in controls (Fig. 4B) . Insulin (100 nM) stimulated glucose uptake by 37% in control cells compared with ,2% in TF-KD cells, and by 52% compared with 30%, respectively, at 1 mM insulin. Akt phosphorylation after insulin stimulation was 70% decreased (P = 0.014) in TF-KD cells compared with controls ( Fig. 4C and 4D ).
Knocking down TF mRNA in adipocytes modulated many pathways including genes associated with insulin action and sensitivity
Comparison of triplicate cultures of TF-KD cells with control shRNA-treated SGBS cells at day 14 of differentiation by RNA-sequencing analysis identified genes modulated by TF. This genome-wide expression profiling analysis identified 465 differentially expressed genes (DEGs; log 2 fold change 60.4; probability .70%) in TF-KD cells compared with control cells (Supplemental Table 9 ). Using more stringent criteria, namely requiring that the minimum expression level of one group and maximum expression of the other group do not overlap, and differ by at least 30% of the mean expression level, 100 DEGs remained significant (shown as heat map in Fig. 5A ). Among the 465 DEGs in DAVID analysis, downregulated genes were enriched for cholesterol biosynthesis (GO:0006695; P = 2.27 3 10 214 ), fatty acid metabolism (GO:0006633; P = 8.16 3 10 24 ), insulin signaling (hsa04910; P = 1.37 3 10 23 ), and mitochondrial function (GO:0005739; P = 3.63 3 10 24 ), whereas upregulated genes were involved in extracellular matrix organization (GO:0030198; P = 2.68 3 10
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), and chemokine activity (GO:0008009; P = 8.01 3 10 24 ;
Supplemental Table 10 ). Ingenuity pathway analysis similarly suggested enrichment of 65 canonical pathways (P , 0.05) among DEGs, including strongest enrichment of the superpathway of cholesterol biosynthesis (P = 7.94 3 10 212 ; Supplemental Table 11 ). Selected DEGs, including genes involved in glucose transport (GLUT4), mitochondrial function (CPT1B, UCP2), Wnt-pathway/ insulin sensitivity (SFRP4), chemokine activity/cell-cell interaction (CXCL1), and genes with possible roles in obesity (CES1, RARRES2) were independently validated by qRT-PCR ( Fig. 5B ; see Supplemental Table 12 for qRT-PCR primer sequences). Among the genes downregulated in TF-KD cells, 32 (e.g., PCBD1, TM7SF2, SHMT1, ACSS2, LACTB2, and ADIPOQ) also showed positive correlation in adipose tissue with S I in the AAGMEx cohort (17) . Similarly, among the genes upregulated in TF-KD cells, we reported negative correlation with S I of 32 (e.g., HSD11B1, ALDH3B1, STC2, SFRP4, and CES1) in the AAGMEx cohort (17) . Increased TFRC in the TF-KD cells is also consistent with the human phenotypes (Supplemental Fig. 3 ) and with the decreased iron content of those cells (Fig. 4A) . Thus, our in vitro studies identified target genes and pathways, many shared in the human AAGMEx cohort, through which TF in adipocytes may modulate iron homeostasis and S I .
Manipulating iron content of SGBS cells recapitulated the effects of TF knockdown on transcript levels Because TF-KD cells have decreased intracellular iron, we asked if modulating iron content would be sufficient to cause the changes in the levels of the selected DEGs analyzed in Fig. 5B . Addition of iron to native SGBS cells had the opposite effect of TF-KD, and chelation of iron with desferrioxamine had the same effect as TF-KD on the transcripts, for transcripts that were decreased or increased in the TF-KD cells (Fig. 5C ).
Discussion
We have demonstrated that levels of TF mRNA in adipocytes, which are regulated by polymorphisms in the TF gene, are a major determinant of S I in African Americans. This finding was replicated in two cohorts of European descent. The variations in TF expression were a cause rather than a result of insulin resistance insofar as the variation in TF and its association with S I were related to polymorphisms in the TF gene promoter/enhancer region. Specificity of the association for adipocyte transferrin was demonstrated by several findings: (1) TF mRNA was detected in adipocytes but not stromal vascular cells from the adipose tissue biopsy specimens, and is only seen in cultured adipocytes after differentiation; (2) analysis of TF expression in muscle tissue revealed no association with S I ; (3) analysis of expression data in the STARNET and GTEx cohorts confirms the regulation of TF in adipose tissue by the polymorphisms revealed in this study but not in liver and muscle; and (4) serum transferrin, which is predominantly derived from the liver, did not vary as a function of the TF polymorphisms.
To understand the role of genetic factors in determining insulin resistance and the etiology of T2D, most published studies have focused on identifying susceptibility loci by genetic association studies in human populations (24) . Genetic association studies provide valuable insights on genetic architecture of disease susceptibility, but genetic regulatory mechanisms (i.e., genes specifically modulated by these SNPs) and influence on cellular and molecular processes relevant to insulin resistance, remain obscure. The genetic etiology of most common diseases including insulin resistance is complex, and gene-gene, and gene-environment (e.g., diet, lifestyle) interactions may obscure the identification of these genetic regulatory factors. Studies in animal models and human cohorts suggest that insulin resistance results from derangement in expression of genes in key biological pathways in tissues involved in glucose homeostasis, and genetic variants, such as SNPs determine the expression level of a subset of insulin resistanceassociated genes. In this study, we focused on identifying genetic regulatory mechanisms of iron metabolism pathway genes. In the iron metabolism pathway, expression of the TF transcript in adipose tissue was strongly associated with S I and eQTL analysis suggests the presence of strong cis-regulatory SNPs that regulate the expression of TF mRNA in adipose tissue. Bioinformatic analysis by HaploReg, version 4.1 (http:// archive.broadinstitute.org/mammals/haploreg/), which uses epigenetic regulatory information, including chromatin state segmentations (ChromHMM model) from the Roadmap Epigenomics Project, suggests that these regulatory SNPs are located in promoter and putative enhancers (Histone H3K9ac and H3K4me1 marks) of the TF gene ( Supplemental Fig. 4 ). The cis-eSNP for rs6796795, for example, overlaps with the binding motif of transcription factor Pou3f2, Roaz, STAT, and that of rs6785596 overlaps the binding motif of transcription factors Foxj2, HNF1, HNF6, Ncx, and Nkx6-1. The eSNPs in the intronic enhancer region and in the promoter region are not in strong linkage disequilibrium and may indicate independent regulatory elements. All these studies in human cohorts suggest a role for genetic regulation of adipose tissue TF transcript level in modulating S I . Transferrin is the major serum iron-binding and -transport protein, and serum TF is derived mainly from hepatic synthesis. The fact that the mRNA levels for TFRC are inversely regulated with TF in adipocytes suggests that adipocyte TF expression has functional consequences for adipocyte iron homeostasis. Iron downregulates TFRC mRNA by releasing stabilizing iron regulatory proteins (25) , so higher TFRC expression with lower TF suggests lower intracellular iron. This was confirmed directly by the demonstration that TF-KD cells have decreased intracellular iron levels. In humans, that eSNPs regulating TFRC are less significantly associated with transcript levels and with a smaller effect size than those regulating TF also suggests that the correlation of TFRC with TF expression is predominantly a consequence rather than a cause of the observed adipocyte phenotype. The lack of association of the TF polymorphisms with serum TF or ferritin is consistent with the specificity of the polymorphisms for adipocyte expression and argues that overall systemic iron balance is not affected by adipocyte TF expression, insofar as ferritin is a generally reliable reporter of tissue iron stores even in the presence of diabetes and diabetic complications (26) (27) (28) (29) (30) . Another level of complexity in the system is that iron downregulates TF expression postranscriptionally, so the total picture of iron regulation in adipose tissue is likely to be highly complex (31) .
TF expression has been reported in adipocytes and its expression linked to successful adipocyte differentiation and mitochondrial function (15) . The importance of iron to adipocyte function has also been reported (32) . We have previously shown that iron regulates adipocyte expression of adiponectin (7) and leptin (16) , leading us to hypothesize that the adipocyte not only senses macronutrient status to regulate feeding and energy balance through hormones such as these but also serves as an iron sensor to coordinate the ability to oxidize fuel with fuel availability. To achieve this iron-sensing function, the adipocyte also expresses several otherwise highly Graphs represent mean and SD of six to 12 biological replicates for each condition from two to four independent experiments. (C) Untransfected SGBS cells were treated with iron or iron plus iron chelator (DFO) for 24 h, and qRT-PCR was performed for select genes. mRNA levels were normalized to levels in untreated cells (value of 1 on the ordinate). Graph represents mean 6 SEM of three independent studies. *P , 0.05 compared with untreated control. DFO, desferrioxamine.
restricted proteins involved in iron homeostasis, including the iron export channel ferroportin (SLC40A1) (7) and its regulator hepcidin (HAMP) (33) .
The importance of TF expression to adipocyte function and differentiation, coupled with the fact that functionally important variations in adipocyte TF expression are independent of serum TF levels, suggests a paracrine or autocrine function for adipocyte TF expression. Obesity has been reported to cause a shift in iron distribution from adipose tissue macrophages to adipocytes (34) , and it has been hypothesized that this could play a causal role in obesity-induced insulin resistance (35) . Any iron released from macrophages would first have to be TF bound to be efficiently internalized by adipocytes, thus the redistribution might be highly dependent upon local TF availability. The possible adaptive consequences of this redistribution in situations of high fat feeding are not known, but one can speculate that in situations of caloric or fat excess, transfer of iron would facilitate mitochondrial expansion in the adipocytes (15) [so-called beiging (36) ] that, in turn, would allow the adipocytes to participate in fatty acid oxidation.
Insulin resistance in the TF-KD cells was shown by decreased insulin-stimulated glucose uptake-both a rightward shift in dose responsiveness and decreased maximal stimulation-and by impaired insulin signal transduction (decreased Akt phosphorylation). It should be noted that although the maximal insulin stimulation is SGBS cells was modest, the levels were similar to those reported in this adipocyte model (23) . The molecular mechanisms for the insulin resistance in both the cells and in the individuals with low adipocyte TF expression are unknown, but the expression profiling of the TF-KD cells reveals several plausible candidates. The decrease in GLUT4 expression in TF-KD cells is certainly one mechanism, as decreased glucose uptake into fat is sufficient to cause total-body insulin resistance (37) . Decreased Akt phosphorylation demonstrates additional upstream effects on insulin signaling. Altered mitochondrial function is another hallmark of insulin resistance, and changes in mitochondrial protein expression were observed in the TF-KD cells. Wnt signaling is also implicated in diabetes (38) , although b cell function has been better linked with those pathways than insulin resistance. Finally, altered chemerin (retinoic acid receptor responder protein 2, RARRES2) expression is associated with altered adipogenesis and obesity (39) (40) (41) , so its change in the TF-KD cells could also play a role. That all these pathways are affected by transferrin expression, and that much of the transcriptional profile can be recapitulated solely by manipulating iron availability to cultured adipocytes, suggests a coordinated and possibly adaptive response of insulin action to adipocyte iron availability and is consistent with the hypothesized role of iron as an important determinant of adipose tissue function.
A paradox of these findings is that high adipocyte iron levels, such as induced by high iron feeding, is associated with insulin resistance, and yet the high TFRC suggests that the insulin-resistant, low-TF individuals might have low adipocyte iron levels, assuming the TFRC is indeed, primarily responding to intracellular iron based on the iron regulatory protein mechanism. The fact that adiponectin expression is decreased in humans and adipocytes with low TF expression but is also downregulated by high iron feeding (7) suggests that the overall adipocyte phenotype and gene expression profile is dependent on factors in addition to intracellular iron levels. We have previously demonstrated that the effects of iron are diet dependent; for example, in states of high fat feeding, the accelerated rates of fat oxidation induced by high iron can have salutary effects on body weight and S I (8) . Intracellular partitioning of iron is complex (42) , so it is also feasible that iron taken up by non-TF mechanisms in situations of TF deficiency may be targeted to different subcellular compartments than iron entering the cell through the TFRC. Mechanisms such as these might explain the altered relation of serum ferritin, a reliable indicator of tissue iron, with insulin resistance in individuals with low adipocyte TF. Finally, high iron levels that cause insulin resistance result in increased iron in adipocytes and macrophages, so both cell types may participate in the final phenotype. Overall, however, all the results are consistent with the conclusion of other groups that fine-tuned iron availability is essential for optimal adipocyte function (15) , and that additional understanding of the details of iron fluxes, trafficking, and chaperoning is required.
We conclude that genetic regulation of TF expression in adipose tissue plays a novel role in regulating S I . Decreased levels of adipocyte TF are sufficient to cause insulin resistance in humans and in a cell culture model. Changes in adipocyte TF, in the absence of obvious changes in whole-body iron homeostasis, suggest that local iron fluxes within adipose tissue are likely to be responsible for the adipocyte phenotype. These results provide more evidence for the importance of iron metabolism in diabetes and the importance of coordination of iron availability with metabolic regulation. Additional longitudinal analysis of individuals with altered adipocyte TF is needed. For example, the AAGMEx cohort excluded those with diabetes to allow analysis of prediabetic subphenotypes including obesity, insulin deficiency, and insulin resistance. Thus, the questions of the rate at which they will convert to diabetes, and the interactions of dietary factors including iron in that conversion, remain unanswered. Development of an animal model should also allow mechanistic studies under conditions of controlled dietary manipulations. All this work may result in definition of tissue iron levels that are optimal for preventing diabetes that may be in a much narrower range than the extremely broad "normal" range (1, 10) .
